If you think you may be at risk for cancer, you should discuss this concern with doctor. You may want to ask about reducing your risk and about a schedule for checkups. Over time, several factors may act together to cause normal cells to become cancerous.
The most well-known ways to protect you from various cancer types, are the following:
---------------------------------------------------------------------------------------------------------- ROLE OF SCREENING IN CANCER (SUMMARY).
Screening is the process of early diagnosis of a disease ie identifiication of disease or risk factor in its pre symptomatic or preclinical stage. Concept of screening developed way back in 1940.
Impact of screening on human health slowly progressed, from obvious changes in the vital statistics such as the decline in incidence of syphilis, to less obvious changes such as the decline in mortality of cancer of the cervix, to finally more subtle changes, such as the impact of mammographic screening on breast cancer mortality.
Methods of evaluation had therefore to adapt, evolving from simple surveys to case-control studies, cross sectional studies, population based studies and now randomized controlled trials.
A report by the National Cancer Policy Board and the Institute of Medicine, estimated that a 19% decline in the rate at which new cancers occur and a 29% decline in the rate of cancer deaths could be achieved by 2015 through changes in behavior and greater dissemination of proven technologies, including cancer screening.
ADVANTAGE OF SCREENING
IDEAL SCREENING TEST
IDEAL CANCER FOR SCREE
ASSESSMEN OF SCREENING PROGRAM
In assessing effectiveness of screening technologies, the RANDAMIZED CONTROLE TRIALS (RCT) has been the gold standard. It is the most powerful methodology for demonstrating the value of screening in comparison to an unscreened group. RCTs minimize biases inherent in other designs, especially lead time, length bias, selection bias, and over diagnosis .
DRAWBACKS OF SCREENING
Physical, economic, and psychological consequences of false-positives and false-negatives,
The potential for over diagnosis
SCREENING FOR CANCER CERVIX
Cervical cancer is one of the leading cancer as well as leading cause of cancer deaths among women in developing countries.
Pap (papinocolaou) smear ,is the screening method of choice in developed countries.
Since the implmentation of pap smear screening program in 1949, the incidence rate of invasive cervical cancer has decreased from more than 30 per 100,000 women to less than 5,and the mortality rate has decreased from 12 to about 3 per 100,000.These excellent results have been obtained through a combination of a population based program with a central registry.
CURRENT RECOMMENDATIOS FOR SCREENING CANCER CERVIX ARE
Screening should start approximately 3 years after the onset of sexual activity ,and the interval is variable from 1 to 3 years.
More than one-half of invasive cervical cancers occur in women who have never been screened, or at least not within the previous 5 years.
ALTERNATIVE METHODS FOR CANCER CERVIX SCREENING
Unaided visual inspection ,
Cervicography,
Visual inspection after application of acetic acid (VIA),
VIA with magnification,and
Human papilloma virus (HPV)DNA testing
Currently,an IARC funded cross-sectional study is being conducted in 4 Indian locations (Mumbai, Calcutta, Jaipur and Trivandrum) to evaluate the test charecterstics of various screening methods on a large sample of 30,000 women. The sensitivity and specificity of pap smear, HPV DNA testing ,and VIA are simultaneously evaluated. Results of this study are awaited .
SCREENING FOR BREAST CANCER
Breast cancer is one of the most significant health concerns in the United States.
It is the most commonly diagnosed cancer in women and the second leading cause of cancer death in women.
The risk of being diagnosed with breast cancer increases with age.
Screening significantly contributed to the 23.5 percent decline in breast cancer mortality from 1990 to 2000.
National Cancer Institute has an online tool (http://www.cancer.gov/bcrisktool).
Another tool is available at http://www.breastcancerprevention.org/raf_source.asp.
CURRENT RECOMMENDATIOS FOR SCREENING BREST CANCER ARE
For women 40 years and older who are at average risk, most major health organizations endorse mammographic screening every one to two years, and every year after age 50 as long as the woman is healthy.
The clinical breast examination may also be important, because up to 10 percent of breast cancers may be clinically evident while being silent mammography. For those with breast cancer genetic mutations, mammography should begin at age 25, or at an age 10 years younger than the youngest case diagnosed in the family.
SCREENING FOR LUNG CANCER
Lung cancer is the major cause of cancer- related mortality in both men and women in industrialised countries and causes more deaths than colorectal, breast and prostate cancer combined.
CURRENT RECOMMENDATIOS FOR SCREENING LUNG CANCER ARE
American Cancer Society, 2001 Recommends against routine screening of asymptomatic persons. Individuals interested in early detection should be encouraged to participate In trials.
American College of Chest Physicians, 2003 Recommends that individuals should only be screened in the context of well-designed clinical trials.
US Preventive Services Task Force, 2005 Evidence is insufficient to recommend for or against screening asymptomatic persons for lung cancer.
CONCLUSIONS FOR ROLE OF SCREENING IN CANCER
Medical screening has existed for about 60 years, and has a very rich history.
The preclinical identification of disease has been a major component of modern medicine and public health.
Screening has contributed to some of major successes of modern medicine .
DR SHASHIKANT SAINI
CONSULTANT SURGICAL ONCOLOGY
BMCHRC
--------------------------------------------------------------------------------------------------------------------